Shanghai Rendu Biotechnology Co., Ltd.

688193

CNE1000059K5

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
30.04 ^CNY	+0.84%		+9.48%	-33.42%

Apr. 02	Tranche Update on Shanghai Rendu Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024.	CI
Feb. 27	Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Shanghai Rendu Biotechnology Co., Ltd. authorizes a Buyback Plan.

February 17, 2024

The Board of Directors of Shanghai Rendu Biotechnology Co., Ltd. has authorized a buyback plan on February 18, 2024.

Latest news about Shanghai Rendu Biotechnology Co., Ltd.

Tranche Update on Shanghai Rendu Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024.	Apr. 01	CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Shanghai Rendu Biotechnology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.	Feb. 18	CI
Shanghai Rendu Biotechnology Co., Ltd. authorizes a Buyback Plan.	Feb. 17	CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-31	CI
Shanghai Rendu Biotechnology Gets Certificate for Registration of HIV Kit	23-06-21	MT
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Shanghai Rendu Biotechnology Co., Ltd.(SHSE:688193) added to Shanghai Stock Exchange Composite Index	23-03-30	CI
Shanghai Rendu Biotechnology Co., Ltd.(SHSE:688193) added to Shanghai Stock Exchange A Share Index	23-03-30	CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-12	CI
Coland Holdings Limited cancelled the acquisition of an unknown stake in Shanghai Rendu Biotechnology Co., Ltd.	14-01-24	CI
Coland Holdings Limited agreed to acquire an unknown stake in Shanghai Rendu Biotechnology Co., Ltd. for TWD 180 million.	13-01-25	CI

Chart Shanghai Rendu Biotechnology Co., Ltd.

Duration

Period

Chart Shanghai Rendu Biotechnology Co., Ltd.

More charts

Shanghai Rendu Biotechnology Co Ltd is a China-based company mainly engaged in the research, development and sales of molecular diagnostic reagents. The Company utilizes ribonucleic acid (RNA) isothermal amplification technology to provides multiple series of diagnostic reagents, including respiration series, reproduction series, enterovirus series, blood-borne diseases series and other diagnostic reagents. The Company also designs and manufactures medical instruments. The Company mainly sells its products within domestic market.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-04-29 - Q4 2023 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
SHANGHAI RENDU BIOTECHNOLOGY CO., LTD.	-33.42%	166M
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B